Genenta Science S.p.A.
GNTA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $4,582 | $3,691 | $29,795 | $37,240 |
| Short-Term Investments | $8,078 | $15,084 | $0 | $0 |
| Receivables | $1,448 | $2,004 | $1,562 | $1,421 |
| Inventory | $0 | $0 | $145 | $76 |
| Other Curr. Assets | $365 | $477 | $219 | $22 |
| Total Curr. Assets | $14,473 | $21,256 | $31,721 | $38,759 |
| Property Plant & Equip (Net) | $43 | $57 | $112 | $23 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $88 | $53 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $220 | $981 | $1,605 | $1,245 |
| Total NC Assets | $351 | $1,091 | $1,716 | $1,268 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $14,824 | $22,347 | $33,438 | $40,027 |
| Liabilities | – | – | – | – |
| Payables | $318 | $295 | $1,194 | $190 |
| Short-Term Debt | $13 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,768 | $1,441 | $989 | $945 |
| Total Curr. Liab. | $2,099 | $1,736 | $2,184 | $1,135 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $228 | $179 | $116 | $31 |
| Total NC Liab. | $229 | $179 | $116 | $31 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $15 | $0 | $0 | $0 |
| Total Liabilities | $2,328 | $1,915 | $2,300 | $1,166 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $68,462 | $67,344 | $66,604 | $65,881 |
| Retained Earnings | -$56,056 | -$47,143 | -$35,466 | -$27,020 |
| AOCI | $89 | $231 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $12,496 | $20,432 | $31,138 | $38,861 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $14,824 | $22,347 | $33,438 | $40,027 |
| Net Debt | -$4,567 | -$3,691 | -$29,795 | -$37,240 |